AF Ablation With High Power Short Duration RF
Recruiting · NCT05777551 · Observational (researchers observe without assigning treatment) · Lead sponsor: Clinica Mediterranea
View the official record on ClinicalTrials.gov →What this trial is about
This is a prospective, multi-center, research study designed to evaluate the safety and efficacy of pulmonary vein (PV) isolation with high power short duration radiofrequency energy in patients with paroxysmal/persistent atrial fibrillation (AF). Subjects with paroxysmal/persistent AF will undergo catheter ablation using commercially approved devices (mapping system and catheters). Patients will be followed up for 12 months to measure the recurrence of AF and its predictors. The primary endpoint will be to investigate the association between clinical and procedural characteristics and the efficacy and the safety of PVI performed with HPSD. At least 850 consecutive will be enrolled to have an adequate statistical power for the analysis of the primary endpoint. We assume that the freedom form AF recurrence at 12 months will be 80%. Expected R\^2 (Cox-Snell) 0.1. Candidate variables to be included in the model:10. Shrinkage level: 0.9. Based on these assumption the minimum number of patients is 850 with 170 events and EPP 17.
Who can take part
Inclusion criteria
- Patients with paroxysmal/persistent AF who signed the informed consent
- Patients on active oral anticoagulation
Exclusion criteria
- Previous ablation for AF
- Patients with LVEF\<35%
- Women potentially pregnant
- Contraindications to X-ray exposure
- Congenital heart disease or cardiac surgery within 1 month
Where it is running
9 locations listed.
- Università Politecnica delle Marche - Ancona, Italy
- Ospedale Civile di Asti - Asti, Italy
- Royal Papworth Hospital - Cambridge, United Kingdom
- Clinica Mediterranea - Naples, Italy
- Centre Cardiologique Du Nord - Paris, France
- Città della Salute e della Scienza di Torino, Dipartimento di Scienze Mediche della Università di Torino. - Torino, Italy
- Clinica Montevergine - Mercogliano, AV, Italy
- Maria cecilia Hospital - Cotignola, RA, Italy
- Ospedale di Conegliano - Conegliano, TV, Italy